| 12115154 |
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) |
Simeon Bowers, Mark Karbarz, Jiang Zhu, Jonathan William Bourne, Anjali Pandey |
2024-10-15 |
|
| 11944619 |
Phenylalanine small organic compounds to directly modulate PCSK9 protein activity |
Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers |
2024-04-02 |
|
| 11945782 |
Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity |
Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers |
2024-04-02 |
|
| 11925637 |
Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use |
Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers |
2024-03-12 |
|
| 11891369 |
Compounds for binding proprotein convertase subtilisin/kexin type 9 |
Anjali Pandey, Simeon Bowers, Jonathan William Bourne |
2024-02-06 |
|
| 11771710 |
Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands |
Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann |
2023-10-03 |
|
| 11026957 |
Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands |
Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann |
2021-06-08 |
|
| 10980801 |
Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use |
Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers |
2021-04-20 |
|
| 10865185 |
Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity |
Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers |
2020-12-15 |
|
| 10821106 |
Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity |
Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers |
2020-11-03 |
|
| 10688114 |
Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity |
Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann |
2020-06-23 |
|
| 10568882 |
Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use |
Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers |
2020-02-25 |
|
| 10307433 |
Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity |
Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann |
2019-06-04 |
|
| 10287317 |
Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels |
Michael M. Muehlemann, Kyle D. Monroe, Jonathan William Bourne, Margaret Thompson Reece, Vesa Nevalainen +1 more |
2019-05-14 |
|
| 10034892 |
Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity |
Jonathan William Bourne, Kyle D. Monroe, Michael M. Muehlemann |
2018-07-31 |
|
| 9656956 |
Benzene, pyridine, and pyridazine derivatives |
Kenneth He Huang, Jeron Eaves, Gunnar J. Hanson, James Marvin Veal, Lifeng Geng +1 more |
2017-05-23 |
|
| 8309548 |
Benzene, pyridine, and pyridazine derivatives |
Kenneth He Huang, Jeron Eaves, Gunnar J. Hanson, James Marvin Veal, Lifeng Geng +1 more |
2012-11-13 |
|
| 7928135 |
Benzene, pyridine, and pyridazine derivatives |
Kenneth He Huang, Jeron Eaves, Gunnar J. Hanson, James Marvin Veal, Lifeng Geng +1 more |
2011-04-19 |
|
| 7906529 |
Benzene, pyridine, and pyridazine derivatives |
Kenneth He Huang, Jeron Eaves, Gunnar J. Hanson, James Marvin Veal, Lifeng Geng +1 more |
2011-03-15 |
|
| 7678803 |
Quinazoline derivatives for the treatment of cancer |
Kenneth He Huang, James Marvin Veal, Emilie Smith, Wei Ma, Andy J. Ommen |
2010-03-16 |
|
| 7358370 |
Benzene, pyridine, and pyridazine derivatives |
Kenneth He Huang, Jeron Eaves, Gunnar J. Hanson, James Marvin Veal, Lifeng Geng +1 more |
2008-04-15 |
|
| 7282506 |
2,8-disubstituted naphthyridine derivatives |
Gunnar J. Hanson, Roy W. Ware, He Huang |
2007-10-16 |
|
| 7119203 |
Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
Daniel P. Becker, Louis Bedell, Terri Boehm, David L. Brown, Jeffery Carroll +25 more |
2006-10-10 |
$25,405,000 |
| 7115632 |
Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
Louis Bedell, Joseph McDonald, Daniel P. Becker, Rao N Shashidhar, John N. Freskos +4 more |
2006-10-03 |
|
| 6890928 |
Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
John N. Freskos, Yvette M. Fobian, Daniel P. Becker, Louis Bedell, Terri Boehm +12 more |
2005-05-10 |
$22,787,000 |